Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Apr 15, 2023; 15(4): 632-643
Published online Apr 15, 2023. doi: 10.4251/wjgo.v15.i4.632
Published online Apr 15, 2023. doi: 10.4251/wjgo.v15.i4.632
Ref. | Patients, N | Cancer stage | Blood source | PoV sample | CTC isolation method | OS, median (95%CI) | PFS, median (95%CI) | Main findings |
Bissolati et al[36], 2015 | 20 | Resectable | PoV, PV | Intraoperative | CellSearch | CTCs (-): 23.1 (15.1-31.1) mo, CTCs (+): 26.2 (18.7-33.8) mo | CTCs (-): 19.4 (10.9-27.8) mo, CTCs (+): 18.9 (10.4-27.3) mo | PoV CTC-positive patients had a higher rate of liver metastases than CTC-negative patients. |
Tien et al[29], 2016 | 41 | Resectable | PoV, PV | Intraoperative | CMx platform | Not shown | Not shown | Number of CTCs in the PoV was the only significant risk factor of liver metastases within 6 mo after surgery. |
Liu et al[23], 2018 | 29 | Locally advanced, metastatic | PoV, PV | Transabdominal US-guided | ClearCell FX system | CTCs < 150/7.5 mL: 19.8 (16.8-25.4) wk, CTCs ≥ 150/7.5 mL: 9.2 (7.8-11.8) wk | Not shown | Higher CTC count in the PoV was associated with liver metastases and shorter OS. |
Chapman et al[30], 2020 | 14 | All | PoV, PV | EUS-guided | CellSearch | CTCs < 185/7.5 mL: 40.0 wk, CTCs ≥ 185/7.5 mL: 12.8 wk | CTCs < 185/7.5 mL: 75.4 wk, CTCs ≥ 185/7.5 mL: 29.5 wk | Every 10 CTC increase in the PoV was associated with a 5% and 4% increase in the likelihood of progression and death, respectively. |
Padillo-Ruiz et al[38], 2021 | 35 | Resectable | PoV, CV | Intraoperative | IsoFluxTM | CTCs < 185/mL: 24.5 (19.6-29.4) mo, CTCs ≥ 185/mL: 10.0 (7.4-12.5) mo | Not shown | Higher number of CTCs in the PoV was associated with poorly differentiated cancer and shorter OS. |
Pan et al[48], 2021 | 32 | Resectable | PoV, PV | Intraoperative | CanPatrolTM | Not shown | Not shown | Mesenchymal CTCs in the PoV ≥ 1/5 mL was a significant risk factor for metastasis, PFS, and OS. |
White et al[40], 2021 | 34 | Resectable | PoV, PV | Intraoperative | CellSearch | Not shown | Not shown | Patients with undetectable PoV CTCs showed a higher 18-mo survival rate (100%). |
Zhang et al[31], 2021 | 31 | All | PoV, PV | EUS-guided | Cyttel detection kit | Not shown | Not shown | The number of PoV CTCs, especially mesenchymal CTCs, was positively correlated with the advanced stage. |
Choi et al[32], 2022 | 33 | All | PoV, PV | Intraoperative | SMART | CTCs < 3/7.5 mL: NA, CTCs ≥ 3/7.5 mL: 16.5 mo | CTCs < 3/7.5 mL: 13.4 mo, CTCs ≥ 3/7.5 mL: 7.5 mo | Higher number of PoV CTCs was associated with higher stage, lymph node metastasis, and poorer PFS and OS. |
Song et al[37], 2020 | 32 | Resectable | PoV, PV | Intraoperative | Microfabricated Filter | CTCs < 1/10 mL: 40.0 mo, CTCs ≥ 1/10 mL: 17.6 mo | Not shown | CTC count in the PoV was not significantly associated with OS. |
- Citation: Ko SW, Yoon SB. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer. World J Gastrointest Oncol 2023; 15(4): 632-643
- URL: https://www.wjgnet.com/1948-5204/full/v15/i4/632.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i4.632